Tehran University of Medical Sciences

Science Communicator Platform

Share By
Pulmonary Complications of Monogenic Patients With Common Variable Immunodeficiency: Covid-19 Perspectives Publisher



S Delavari SAMANEH ; M Esmaeili MARZIE ; F Salami FERESHTE ; Se Rasouli Seyed ERFAN ; S Fekrvand SABA ; My Marzbali Mahsa YOUSEFPOUR ; N Fathi NAZANIN ; H Abolhassani HASSAN
Authors

Source: Turkish Journal of Immunology Published:2024


Abstract

Pulmonary complications are one the main causes of morbidity and mortality in patients with common variable immunodeficiency (CVID). Although CVID pathogenesis is not completely understood, several genes have been identified to mainly regulate the process of terminal B-cell differentiation, antibody isotype maturation and long-life memory/plasma cell generation. The link between underlying genetic defects and the prognosis of developing different clinical complications like different pulmonary manifestations is still elusive. We provide an overview of recent advancements in the monogenic form of CVID which lead to dysregulation of B-cells at different levels of cytokine stimulations, intracellular signaling, transcription-factor activation, gene transcription and epigenetic controls and predispose patients to different pulmonary complications. The susceptibility to Coronavirus disease 2019 pulmonary complications was discussed in these patients. Monogenic forms of CVID have a distinct pattern in different infectious and non-infectious pulmonary manifestations including autoimmunity, atopy, lymphoproliferation, and cancer. © 2024 Elsevier B.V., All rights reserved.
Other Related Docs
5. Updates of Cancer Hallmarks in Patients With Inborn Errors of Immunity, Current Opinion in Allergy and Clinical Immunology (2022)
7. The Clinical and Immunological Features of Patients With Primary Antibody Deficiencies, Endocrine# Metabolic and Immune Disorders - Drug Targets (2018)
10. Agammaglobulinemia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management, Endocrine# Metabolic and Immune Disorders - Drug Targets (2020)